XCUR – Exicure Inc.
Exicure, Inc.XCUR
$4.42Name : Exicure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $28,140,834.00
EPSttm : -0.79
Exicure, Inc.
$4.42
0.34%$0.015
XCUR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.4
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
4.58
Target Price
10.33
Analyst Recom
1
Performance Q
-26.42
Upside
-327.0%
Beta
3.92
Ticker: XCUR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | XCUR | 3.64 | N/A | N/A | 0 |
| 2026-03-03 | XCUR | 3.56 | N/A | N/A | 0 |
| 2026-03-04 | XCUR | 3.57 | N/A | N/A | 0 |
| 2026-03-05 | XCUR | 4.05 | N/A | N/A | 0 |
| 2026-03-06 | XCUR | 4.16 | N/A | N/A | 0 |
| 2026-03-09 | XCUR | 4.17 | N/A | N/A | 0 |
| 2026-03-10 | XCUR | 3.9 | N/A | N/A | 0 |
| 2026-03-11 | XCUR | 4.14 | N/A | N/A | 0 |
| 2026-03-12 | XCUR | 3.94 | N/A | N/A | 0 |
| 2026-03-13 | XCUR | 3.94 | N/A | N/A | 0 |
| 2026-03-17 | XCUR | 4.68 | N/A | N/A | 0 |
| 2026-03-18 | XCUR | 4.63 | N/A | N/A | 0 |
| 2026-03-19 | XCUR | 4.84 | N/A | N/A | 0 |
| 2026-03-20 | XCUR | 4.43 | N/A | N/A | 0 |
| 2026-03-23 | XCUR | 4.59 | N/A | N/A | 0 |
| 2026-03-24 | XCUR | 4.65 | N/A | N/A | 0 |
| 2026-03-25 | XCUR | 4.51 | N/A | N/A | 0 |
| 2026-03-26 | XCUR | 4.69 | N/A | N/A | 0 |
| 2026-03-27 | XCUR | 4.5 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-02 | XCUR | 3.63 | - | - | - |
| 2026-03-03 | XCUR | 3.68 | - | - | - |
| 2026-03-04 | XCUR | 3.64 | - | - | - |
| 2026-03-05 | XCUR | 3.98 | - | - | - |
| 2026-03-06 | XCUR | 4.01 | - | - | - |
| 2026-03-09 | XCUR | 4.01 | - | - | - |
| 2026-03-10 | XCUR | 4.05 | - | - | - |
| 2026-03-11 | XCUR | 4.15 | - | - | - |
| 2026-03-12 | XCUR | 4.10 | - | - | - |
| 2026-03-13 | XCUR | 4.03 | - | - | - |
| 2026-03-17 | XCUR | 4.59 | - | - | - |
| 2026-03-18 | XCUR | 4.64 | - | - | - |
| 2026-03-19 | XCUR | 4.90 | - | - | - |
| 2026-03-20 | XCUR | 4.38 | - | - | - |
| 2026-03-23 | XCUR | 4.58 | - | - | - |
| 2026-03-24 | XCUR | 4.64 | - | - | - |
| 2026-03-25 | XCUR | 4.45 | - | - | - |
| 2026-03-26 | XCUR | 4.41 | - | - | - |
| 2026-03-27 | XCUR | 4.58 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-02 | XCUR | -50.00 | -30.14 | 1.49 |
| 2026-03-03 | XCUR | -50.00 | -30.14 | 1.49 |
| 2026-03-04 | XCUR | -50.21 | -30.14 | 1.49 |
| 2026-03-05 | XCUR | -50.00 | -30.14 | 1.49 |
| 2026-03-06 | XCUR | -50.00 | -30.14 | 1.49 |
| 2026-03-09 | XCUR | -49.50 | -30.14 | 1.49 |
| 2026-03-10 | XCUR | -49.50 | -30.14 | 1.49 |
| 2026-03-11 | XCUR | -49.57 | -30.14 | 1.71 |
| 2026-03-12 | XCUR | -50.00 | -30.14 | 1.71 |
| 2026-03-13 | XCUR | -50.00 | -30.14 | 1.71 |
| 2026-03-17 | XCUR | -50.00 | -29.69 | 1.71 |
| 2026-03-18 | XCUR | -50.00 | -29.69 | 1.71 |
| 2026-03-19 | XCUR | -50.00 | -29.69 | 1.71 |
| 2026-03-20 | XCUR | -50.00 | -29.69 | 1.71 |
| 2026-03-23 | XCUR | -50.00 | -30.14 | 1.71 |
| 2026-03-24 | XCUR | -50.00 | -30.14 | 1.71 |
| 2026-03-25 | XCUR | -50.00 | -30.14 | 1.40 |
| 2026-03-26 | XCUR | -50.00 | -30.14 | 1.40 |
| 2026-03-27 | XCUR | -50.00 | -30.14 | 1.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
-50
Institutional Transactions
-30.14
Beta
3.92
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
12
Growth Score
Sentiment Score
32
Actual DrawDown %
98.6
Max Drawdown 5-Year %
-99.6
Target Price
10.33
P/E
Forward P/E
PEG
P/S
P/B
7.17
P/Free Cash Flow
EPS
-0.77
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.5
Return on Equity vs Sector %
-153.3
Return on Equity vs Industry %
-137.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
XCUR
Healthcare
$4.41
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
52.4
Range 1M
61.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
0%
EPS NY
0%
52W%
12.4%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+134.2% upside
Upside
+134.2%
Quality
12
Exicure, Inc.Sector: Healthcare
Industry: Biotechnology
Employees:
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR
Latest News
—
Caricamento notizie per XCUR…
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading